《盈警響號》信基沙溪(03603.HK)料去年盈轉虧 蝕最多2.3億人幣
信基沙溪(03603.HK)公布,相較2020年同年的純利約3,300萬元人民幣(下同),預期截至去年12月31日止年度集團錄得淨虧損不少於2億元但不多於2.3億元。
虧損主要由於集團持有的投資物業公平值收益減少,主要原因是中國瀋陽兩家商城的估值受新冠病毒變異株奧密克戎毒株引發的多地疫情對市場的持續影響,及去年下半年房地產緊縮政策的影響造成市場需求整體降低而調整。
撇除若干一次性或非經常性專案的影響,包括投資物業公平值變動、政府補助及有關上述調整專案的所得稅開支,集團去年核心純利相較2020年同期核心純利8,870萬元,預期減少不多於300萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.